Skip to content

DOKTER ROOBAERT GERLINDE

Active
Private limited companyfounded 201016 yrs activeSchoorbakkestraat(P) 44, 8600 Diksmuide, BelgiumKBO/BCE: BE 0829.335.152
Summary

DOKTER ROOBAERT GERLINDE has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €447k and a net result of €82k. Equity is growing by ~15.3% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2025
88 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability88▼-4
Solvency100▲+7
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 5.96 against 2.87 in 2024; short-term debt: 15.5% and cash: 43.6% of total assets), and 15.6% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
84.4%
Return on assets
15.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 16 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
18 d late
2024
29 d late
2023
29 d late
2022
29 d late
2021
10 d late
2020
3 d early
2019
2 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€447k▲ 18.6%
2024 · €377k
2018: €146k 2019: €174k 2020: €186k 2021: €260k 2022: €301k 2023: €416k 2024: €377k
2018 → 2025
Total assets
€529k▼ 4.0%
2024 · €552k
2018: €219k 2019: €247k 2020: €252k 2021: €335k 2022: €357k 2023: €452k 2024: €552k
2018 → 2025
Net result
€82k▼ 18.8%
2024 · €101k
2018: €6k 2019: €28k 2020: €12k 2021: €74k 2022: €41k 2023: €115k 2024: €101k
2018 → 2025
Working capital
€406k▲ 24.6%
2024 · €326k
2018: €114k 2019: €157k 2020: €185k 2021: €259k 2022: €300k 2023: €416k 2024: €326k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€260k-€301k▲ 15.8%€416k▲ 38.3%€377k▼ 9.4%€447k▲ 18.6%
Operating result€103k-€52k▼ 49.5%€166k▲ 220%€135k▼ 18.7%€115k▼ 15.1%
Net result€74k-€41k▼ 44.5%€115k▲ 181%€101k▼ 12.3%€82k▼ 18.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €103k€103kNet result 2021: €74k€74kOperating result 2022: €52k€52kNet result 2022: €41k€41kOperating result 2023: €166k€166kNet result 2023: €115k€115kOperating result 2024: €135k€135kNet result 2024: €101k€101kOperating result 2025: €115k€115kNet result 2025: €82k€82k20212022202320242025€0€50k€100k€150kOperating result 2023: €166k€166kNet result 2023: €115k€115kOperating result 2024: €135k€135kNet result 2024: €101k€101kOperating result 2025: €115k€115kNet result 2025: €82k€82k202320242025
The operating result has fallen two years in a row; 2025 is 15% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €529k
Fixed assets €41k ▼ 19.1%
Current assets €488k ▼ 2.5%
Equity and liabilities €529k
Equity €447k ▲ 18.6%
Debt €82k ▼ 52.8%
Debt's share of the balance-sheet total falls from 31.7% to 15.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€127k
2024 · €141k
Cash flow
€94k
2024 · €107k
Current ratio
5.96
2024 · 2.87
Debt to equity
0.18
2024 · 0.46
ROE
18.3%
2024 · 26.8%
ROA
15.5%
2024 · 18.3%
Interest coverage
354.97
2024 · 947.70
Debt ≤ 1 year
€82k
2024 · €174k
Income taxes
€38k
2024 · €43k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet Code20242025
Assets
Total assets20/58€552k€529k
Fixed assets21/28€51k€41k
Tangible fixed assets22/27€51k€39k
Plant, machinery and equipment23€2k€1k
Furniture and vehicles24€49k€38k
Financial fixed assets28-€2k
Current assets29/58€501k€488k
Amounts receivable within one year40/41-€4k
Other amounts receivable41-€4k
Current investments50/53€230k€221k
Cash at bank and in hand54/58€245k€231k
Deferred charges and accrued income490/1€25k€33k
Equity and liabilities
Total equity and liabilities10/49€552k€529k
Equity10/15€377k€447k
Contributions10/11€19k€19k=
Outside capital11€19k-
Other1109/19€19k-
Reserves13€358k€428k
Distributable reserves133€358k€428k
Profit (loss) carried forward14€437€0
Amounts payable17/49€175k€82k
Amounts payable within one year42/48€174k€82k
Trade debts44€3k€2k
Suppliers440/4€3k€2k
Taxes, remuneration and social security45€40k€6k
Taxes450/3€38k€1k
Remuneration and social security454/9€2k€4k
Other amounts payable47/48€132k€74k
Accrued charges and deferred income492/3€250€500
Income statement Code20242025
Non-recurring operating income76A€9k€0
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€12k
Other operating charges640/8€1k€634
Gross operating margin9900€142k€127k
Operating profit (loss)9901€135k€115k
Financial income75/76B€9k€5k
Recurring financial income75€9k€5k
Financial charges65/66B€149€357
Recurring financial charges65€149€357
Profit (loss) for the period before taxes9903€144k€120k
Income taxes67/77€43k€38k
Profit (loss) for the period9904€101k€82k
Profit (loss) for the period to be appropriated9905€101k€82k
Appropriation of the result
Profit (loss) to be appropriated9906€101k€82k
Profit (loss) brought forward from the previous period14P€388€437
Transfer from equity791/2€140k€12k
Transfer to equity691/2€101k€82k
To other reserves6921€101k€82k
Profit to be distributed694/7€140k€12k
Return on contributions (dividend)694€140k€12k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
18-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 18 days late
2025
31-12
Financial Liquidity doublescurrent ratio 5.96
Current ratio from 2.87 to 5.96; short-term debt falls from €174k to €82k.
29-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
29-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
31-12
Financial Highest result since 2018net €115k ▲181%
Operating result €166k, net result €115k, both a record.
31-12
Financial Liquidity doublescurrent ratio 12.74
Current ratio from 6.35 to 12.74; short-term debt falls from €56k to €35k.
29-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
10-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 10 days late
2021
31-12
Financial Equity above €200kEq €260k ▲39.7%
4 profitable years in a row build equity to €260k.
28-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
29-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Equity above €150kEq €174k ▲19.2%
2 profitable years in a row build equity to €174k.
Show earlier events
22-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
13-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
13-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Diksmuide · 1 establishment unit since 2010
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Schoorbakkestraat(P) 448600 Diksmuide
Ground area
1,359 m²
Building footprint
142 m²
Volume, LiDAR
654 m³
Parcel 38019B0277/00T000, Flanders · tallest building 8.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Schoorbakkestraat(P) 44 B, 8600 Diksmuide
General medical practice
since 20102.192.635.015
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
38019B0277/00T000 Flanders 1,359 m² 1 · 142 m² 8.8 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded14-09-2010
Fiscal year end31-12
Abbreviation NL DR. ROOBAERT GERLINDE
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry
E-mail:gerlinde.roobaert@telenet.be
Enterprise